MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Chronic Lymphocytic Leukemia Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

1,742 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
1,742 works in the cohort · of 4,299,418page 27 of 35

Labels cover 5 of 1,742 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 1,742 of 1,742 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

affunlabeled
Que peut-on faire pour arrêter le glyphosate ?
Xavier Reboud, Jennifer Gallé
2023· preprint· fr· HAL (Le Centre pour la Communication Scientifique Directe)· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Résultats cliniques et d’imagerie par résonance magnétique de l’évobrutinib (EVO), un inhibiteur de la tyrosine kinase de Bruton (BTKi), dans le traitement de la sclérose en plaques récurrente (SEP-R) sur une période de 2,5 ans dans l’extension en ouvert
Patrick Vermersch, Douglas L. Arnold, Jerry S. Wolinsky, Eva Kubala Hardova, Anastasiia Kinkolykh, Davorka Tomic +1 more
2023· article· fr· Revue Neurologique· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
Ibrutinib and Cardiac Arrythmias
Atooshe Rohani
2021· book-chapter· en· Clinical cases in cardiology· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affno abstractunlabeled
HemlibraMC (émicizumab), hémophilie A avec inhibiteurs du facteur VIII : avis d'introduction à la Liste des produits du système du sang du Québec : avis / rédigé par Simon Bélanger, Julie Nieminen ; coordination scientifique, Yannick Auclair ; sous la direction de Michèle de Guise
Bélanger, Simon auteur, Nieminen, Julie auteur, Auclair, Yannick éditeur intellectuel +2 more
2019· article· fr· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
affno abstractunlabeled
The Bing-Neel Syndrome
Ina Ly, Florian J. Fintelmann, Reza Forghani, Ephraim P. Hochberg, Fred H. Hochberg
2016· book-chapter· en· Medicine
machine prediction:candidate · noneconsensus · none
0
citations
aboutno affunlabeled
Obituary
2016· article· en· Medicine
machine prediction:candidate · noneconsensus · none
0
citations

How this was built: Screen · Findings · About